All Posts
Media

People with COVID-19 Brain Fog Benefit from Photobiomodulation Therapy

People with COVID-19 Brain Fog Benefit from Photobiomodulation Therapy
Contributors
Subscribe to newsletter

Discover how Photobiomodulation Therapy (PBM) utilizes the power of light to stimulate cellular function and restore cognitive clarity, offering new hope to individuals experiencing post-COVID cognitive challenges.

One of the persisting effects of COVID-19 for some individuals is brain fog. This can greatly impact cognitive abilities, memory, and overall mental clarity. However, the latest research, clinical trials, and expert insights surrounding the use of PBM shed light on the potential benefits and promising results of Photobiomodulation Therapy and its role in addressing cognitive impairments.

Learn more about the study here.

Neuronic devices are not medical devices. Neuronic is not providing any medical advice.

These articles might interest you

View all
Event

Advancing Brain Health: Neuronic at the Buck Institute of Ageing

Neuronic presented in California at the Buck Institute for Research on Ageing. Liam Pingree, Co-founder of Neuronic spoke alongside other industry leaders at the conference including Peter Diamandis MD, Eric Verdin MD, Leroy Hood MD, and many more.
Read more
Media

BBC presenter, Lara Lewington’s new brain aging documentary includes Bryan Johnson showcasing Neuronic's device!

Read more
Blog

Long Covid Treatment With Photobiomodulation Therapy: Does it work?

There are numerous approaches to improving brain health and functioning, among them are several techniques that are both non-invasive and non-pharmaceutical, these include light therapy also called photobiomodulation therapy (PBM), peripheral biofeedback (BFB) and brainwave biofeedback or neurofeedback (NFB).
Read more